The WSJ writes about the sad story of Myriad Genetics, who paid $200,000 for a huge coming out party at a conference for their Alzheimer’s drug.
Trouble is, the drug didn’t work, so they’re left with an empty, fancy booth.
Tragically comical.
From the monthly archives:




